Conmed (CNMD) Tops Q1 EPS by 8c; Hikes FY22 Revenue Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.54 -0.12%
EPS Growth %: -3.5%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: -3.5%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $242.3 million versus the consensus estimate of $235.77 million.
GUIDANCE:
Conmed sees FY2022 revenue of $1.105-1.15 billion, versus the consensus of $1.09 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
